Story
Quest Diagnostics Stock Slides on Proposed Medicare Reimbursement Cuts
Quest Diagnostics (NYSE:DGX) shares fell sharply in after-hours trading after federal regulators proposed significant cuts to Medicare reimbursement rates for laboratory services, threatening a key revenue stream for the company and its competitors.
Proposed Rate Cuts Trigger Sell-Off
The stock dropped 5.2% to $232.12 in after-hours trading on Thursday, according to the source. The decline followed a preliminary announcement from the Centers for Medicare & Medicaid Services (CMS) that could reduce payments under the Clinical Laboratory Fee Schedule by up to 15% beginning January 1, 2027.
CMS stated the proposed realignment is based on data from over 6,400 laboratories, which suggested Medicare has been overpaying for these services by approximately 16% compared to private insurers. The agency estimates the change would save taxpayers around $1 billion per year.
Market Impact and Context
The proposed cuts represent a significant headwind for the entire diagnostics sector. Labcorp (NYSE:LH), Quest's primary competitor, also faced the same regulatory pressure, confirming a sector-wide reaction. The sell-off was particularly sharp as it came just hours after Quest's stock had reached a new 52-week high of $248.84 during regular trading.
AdThe after-hours decline erased the day's gains and pushed the stock significantly lower, highlighting the material risk investors see in the proposal. Broader market indices were largely flat, underscoring that the drop was driven by the specific regulatory news rather than a wider economic shift.
Path to Finalization
The proposed rates are not yet final. According to the CMS announcement, laboratories and industry groups will have approximately 30 days to submit formal comments on the preliminary schedule.
CMS is expected to release the final fee schedule for calendar year 2027 in November 2026. This timeline suggests a period of uncertainty is likely to weigh on the stocks of Quest and its peers in the near term.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.